2011Clinical MedicineRequires access

Efficacy of moxifloxacin in treating elderly lower respiratory tract infection

Lili Han

Open publisher page 0 citations

Abstract

Objective To observe the efficacy and safety of moxifloxacin and levofloxacin in the treatment of elderly lower respiratory tract infection.Methods Thirty-eight cases with elderly lower respiratory tract infection were included as treatmet group treated with moxifloxalin(400 mg,iv.qd,7-10 d)and 36 cases as control group with levofloxacin(500 mg,iv.qd,7-10 d).Results The total clinical effective rates of the treatment group and control group were 92.11% and 80.56%,and the baiterial eradication rates were 93.33% and 82.76%.There were significant differences of the above figures between the two groups.Conclusion Moxifloxacin is more effective and safe than levofloxacin in treating elderly lower respiratory tract infection.

About this research paper

What this paper is about

Objective To observe the efficacy and safety of moxifloxacin and levofloxacin in the treatment of elderly lower respiratory tract infection.Methods Thirty-eight cases with elderly lower respiratory tract infection were included as treatmet group treated with moxifloxalin(400 mg,iv.qd,7-10 d)and 36 cases as control group with levofloxacin(500 mg,iv.qd,7-10 d).Results The total clinical effective rates of the treatment group and control group were 92.11% and 80.56%,and the baiterial eradication rates were 93.33% and 82.76%.There were significant differences of the above figures between the two groups.Conclusion Moxifloxacin is more effective and safe than levofloxacin in treating elderly lower respiratory tract infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy and safety of moxifloxacin and levofloxacin in the treatment of elderly lower respiratory tract infection.Methods Thirty-eight cases with elderly lower respiratory tract infection were included as treatmet group treated with moxifloxalin(400 mg,iv.qd,7-10 d)and 36 cases as control group with levofloxacin(500 mg,iv.qd,7-10 d).Results The total clinical effective rates of the treatment group and control group were 92.11% and 80.56%,and the baiterial eradication rates were 93.33% and 82.76%.There were significant differences of the above figures between the two groups.Conclusion Moxifloxacin is more effective and safe than levofloxacin in treating elderly lower respiratory tract infection.

Key concepts: Levofloxacin, Moxifloxacin, Medicine, Respiratory tract infections, Respiratory tract, Lower respiratory tract infection, Internal medicine, Respiratory system

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of moxifloxacin in treating elderly lower respiratory tract infection — Research Paper | ScholarLens